Korea FDA Begins Consultation Services Akin To U.S. FDA's Special Protocol Assessment
This article was originally published in PharmAsia News
Executive Summary
Consultations with KFDA’s National Institute of Food and Drug Safety Evaluation aim to benefit new innovative players, but drug approval process remains independent.